Which GLP-1 is Best for Weight Loss?

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists have transformed weight loss treatment, with clinical trials showing average weight reductions of 15-22% over 68 weeks. However, not every GLP-1 medication works the same way for every person, and selecting the right one requires understanding how these compounds differ and which aligns with your body's unique peptide pathways.

How Do Different GLP-1 Medications Compare?

Semaglutide and tirzepatide are the two primary GLP-1 medications available through PlexusDx, and they work through distinct mechanisms. Semaglutide activates only the GLP-1 receptor, slowing gastric emptying and increasing feelings of fullness to reduce calorie intake. Tirzepatide, by contrast, activates both GLP-1 and GIP receptors, which may enhance weight loss by also improving insulin sensitivity and metabolic regulation. Studies show tirzepatide users lose approximately 2-3 pounds more per month than semaglutide users on average, though individual results vary significantly.

PlexusDx also offers GLP-Squared, a dual-compound injection combining both semaglutide and tirzepatide for patients whose genetic profiles suggest synergistic benefit from both pathways. This approach leverages precision testing to identify whether your body responds better to single-agent therapy or dual activation. The choice between single and dual compounds is not about dose strength but about which receptors your metabolism engages most effectively.

Semaglutide vs. Tirzepatide: Which Causes Better Results?

Semaglutide has been studied longer and shows consistent weight loss of 10-15% of starting body weight over 68 weeks in landmark trials. It is well-tolerated, with gastrointestinal side effects that typically resolve within 4-8 weeks as the body adapts. Semaglutide is available as an injection or oral tablet, giving patients flexibility in delivery method based on personal preference and lifestyle.

Tirzepatide demonstrates superior weight loss in head-to-head comparisons, with some users achieving 20-22% body weight reduction. The dual-receptor activation addresses multiple metabolic pathways simultaneously, making it particularly effective for patients with insulin resistance or metabolic syndrome. Tirzepatide injection and oral formulations are both accessible through PlexusDx, allowing you to choose based on convenience and comfort.

Injectable vs. Oral GLP-1: Which Delivery Method is Right?

Injectable semaglutide and tirzepatide reach peak plasma levels faster and maintain steadier concentrations throughout the week, making them effective for consistent appetite suppression and metabolic effects. Weekly injections require only seven minutes once per week and can be self-administered at home using an auto-injector pen. Many patients report that the injection format provides psychological reinforcement of their commitment to treatment, supporting long-term adherence.

Oral formulations offer convenience for needle-averse patients and integrate seamlessly into daily routines. However, oral GLP-1 medications require special formulation techniques and must be taken on an empty stomach for optimal absorption. PlexusDx provides both injection and oral options at transparent flat monthly prices, so your choice reflects personal preference rather than cost considerations.

Personalized GLP-1 Selection Using Genetic Testing

Not all GLP-1 medications produce identical results in all patients because genetic variation in peptide receptors affects medication response. The PlexusDx Precision Peptide Genetic Test analyzes key variants—including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—that influence how your body responds to GLP-1 therapy. These genetic insights map across 14 metabolic pathways and 49 peptides, revealing whether your system is optimized for GLP-1 monotherapy or benefits from dual-compound activation.

Testing available after your first month of treatment for $99, the Precision Peptide Genetic Test can guide dose optimization and compound selection to maximize weight loss while minimizing side effects. Patients whose genetic profiles show strong GLP1R responsiveness often succeed with semaglutide alone, while those with GIPR variants may achieve better results with tirzepatide or GLP-Squared dual therapy. This precision approach removes guesswork and aligns your medication with your biology.

How to Get Started With PlexusDx GLP-1 Therapy

PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization. Compounded semaglutide injections start at $149 per month across all commitment tiers, and oral semaglutide begins at $249 per month with the same flat-rate pricing model. Tirzepatide injections start at $249 monthly, while dual GLP-Squared compounds begin at $249 for injection format, ensuring your dose can increase without your price increasing.

All medications are compounded by licensed 503A pharmacies and are HSA/FSA eligible, reducing your out-of-pocket cost through tax-advantaged accounts. After completing an initial consultation and receiving your first medication shipment, you can add the Precision Peptide Genetic Test for $99 to refine your personalized treatment plan. PlexusDx supports your weight loss journey with transparent pricing, genetic insights, and access to multiple proven GLP-1 options.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is tirzepatide always better than semaglutide for weight loss?

Tirzepatide produces slightly faster average weight loss than semaglutide, but individual results depend on genetic factors, metabolism, and lifestyle. Some patients achieve excellent results with semaglutide alone, while others benefit from tirzepatide's dual-receptor action or the combination approach of GLP-Squared. PlexusDx Precision Peptide Genetic Testing can identify which compound aligns best with your specific peptide pathways.

Which GLP-1 has fewer side effects?

Semaglutide typically has a slightly lower incidence of nausea and gastrointestinal effects compared to tirzepatide in early weeks, though most side effects resolve as your body adjusts. Tirzepatide may cause slightly more appetite suppression initially due to dual-receptor activation. Both medications are well-tolerated long-term, and side effect severity depends more on individual metabolism than on the medication itself.

How much does semaglutide cost at PlexusDx?

Compounded semaglutide injection starts at $149 per month with flat pricing across all commitment tiers—your dose may increase, but your price won't. Oral semaglutide begins at $249 monthly. Both formats are available without insurance, and costs qualify for HSA/FSA accounts to reduce your net expense.

Can I switch between semaglutide and tirzepatide if one isn't working?

Yes, PlexusDx supports medication transitions based on your response and preference. Some patients switch to optimize results, while others stay with their initial choice. The Precision Peptide Genetic Test ($99) can guide your decision by revealing which compound your genetic profile suggests will be most effective.

What does the PlexusDx Precision Peptide Genetic Test measure?

The test analyzes genetic variants in GLP1R, GIPR, FTO, MC4R, and 10 other pathways affecting 49 peptides to predict your response to semaglutide, tirzepatide, and dual compounds. This 150+ genetic insight profile helps PlexusDx match you with the GLP-1 medication and approach most aligned with your biology for optimal weight loss.

Related Reading

• Glp 1 For Weight Loss 2
• Glp 1 Weight Loss Before And After
• Glp 1 Dosage For Weight Loss
• Glp 1 Receptor Agonist For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.